期刊文献+

周晓园教授中西医结合治疗CD5^(+)弥漫性大B细胞淋巴瘤案例分析 被引量:1

Professor Zhou Xiaoyuan’s Case Analysis of CD5+Diffuse Large B-cell Lymphoma Treated with Integrated Traditional Chinese and Western Medicine
下载PDF
导出
摘要 弥漫性大B细胞瘤是最常见的霍奇金淋巴瘤类型,免疫组化显示CD5^(+)的弥漫性大B细胞瘤患者常常预后较差。周晓园教授采用攻补兼施、中西结合的方法治疗CD5^(+)弥漫性大B细胞瘤患者往往取得良好临床效果,现就其诊治案例和经验进行浅析,以飨读者。 Diffuse large B-cell tumor is the most common type of Hodgkin’s lymphoma.Patients with CD5^(+) diffuse large B-cell tumor often have poor prognosis.Professor Zhou Xiaoyuan’s treatment of CD5^(+) diffuse large B-cell tumor by combining traditional Chinese medicine with western medicine often achieves good clinical effect.This paper analyzes the diagnosis and treatment cases and experience for readers.
作者 张秉芬 ZHANG Bingfen(Shandong Academy of Traditional Chinese Medicine,Jinan 250014,China)
出处 《中外医学研究》 2021年第16期133-135,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 周晓园教授 CD5^(+) 弥漫性大B细胞瘤 案例分析 Professor Zhou Xiaoyuan CD5^(+) Diffuse large B-cell tumor Case analysis
  • 相关文献

参考文献5

二级参考文献26

  • 1Sterdlow SH,Campo E,Harris NL,et al. WHO Classification ofTumors of Haematopoietic and Lymphoid Tissues. Vol 2:IARCWHO Classification of Tumors,No 2. Lyon:IARC Press,2008.
  • 2Hans CP,Weisenburge DD,Greiner TC,et al. Confirmation ofthe molecular classification of diffuse large B-cell lymphoma byimmunohistochemistry using a tissue microarray. Blood,2004;103(1):275 -282.
  • 3Matolcsy A,Chadbum A,Knowles D. de novo CD5-positive andRichter's syndrome-associated diffuse large B cell lymphomas aregenotypically distinct. Am J Pathol,1995 ;147( 1) :207 -216.
  • 4Yamaguchi M,Seto M,Okamoto M,et al. de novo CD5 + diffuselarge B-cell lymphoma:clinicopathologic study of 109 patients.Blood,2002;99(3) :815-821.
  • 5Yamaguchi M,Nakamura N,Suzuki R,et al. de novo CD5 +diffuse large B-cell lymphoma :results of a detailed clinicopatho-logical review in 120 patients. Haematologica,2008 ; 93 (8) :1195-1202.
  • 6Yamaguchi M,Ohno T,Oka K,et al. de novo CD5-positivediffuse large B-cell lymphoma :clinical characteristics andtherapeutic outcome. Br J Haematol,1999; 105(4) :1133 - 1139.
  • 7Niitsu N,Okamoto M,Tamaru JI,et al. Clinicopathologiccharacteristics and treatment outcome of the addition of rituximab tochemotherapy for CD5-positive in comparison with CD5-negativediffuse large B-cell lymphoma. Ann Oncol,2010; 21 (10) :2069 -2074.
  • 8Miyazakil K,Yamaguchi M,Suzuki R,et al. CD5-positivediffuse large B-cell lymphoma :a retrospective study in 337 patientstreated by chemotherapy with or without rituximab. Ann Oncol,2011; 22(7) :1601 -1607.
  • 9Maeshima AM,Taniguchi H,Nomoto J,et al. Secondary CD5 +diffuse large B-cell lymphoma not associated with transformation ofchronic lymphocytic leukemia/small lymphocytic lymphoma(Richter syndrome). Am J Clin Pathol,2009 ; 131 (3) :339 -346.
  • 10张倩,张红宇.原发CD5阳性的弥漫大B细胞淋巴瘤[J].临床血液学杂志,2012,25(2):133-135. 被引量:2

共引文献15

同被引文献21

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部